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Abstract
Background: The aim of this study was to evaluate the clinical and microbiological impact of an antibacterial 
suture (Monocryl® Plus) in the surgical removal of I3M. 
Material and Methods: A “split-mouth”, prospective pilot clinical study was designed involving 20 patients pro-
grammed for the surgical removal of I3M. Each side was randomly sutured with Monocryl® Plus or silk suture 
and removed for microbiological study 72 hours and 7 days after surgery. Presence of SSI, wound bleeding and the 
degree of discomfort associated with each type of suture material (scored by means of a visual analog scale) were 
evaluated. The level of contamination of each material was observed under the scanning electron microscope. 
Results: Wound bleeding upon suture removing was slightly greater after 72 hours and 7 days with black silk su-
ture, though the differences were not statistically significant (p=0.752 and p=0.113, respectively). Patient discom-
fort was very similar with both types of suture material (p=0.861). Only one case of SSI was recorded with black 
silk suture after 72 hours. Microbiologically, the antibacterial suture showed a lesser presence of microorganisms 
(p<0.001, at 72h and p=0.033 at 7th day, respectively). The most common bacterial species included grampositive 
cocci (Streptococcus viridans group, Neisseria spp., Coagulasenegative Staphylococcus and Peptostreptococcus), 
gramnegative cocci (Veillonella), grampositive Bacilli (Lactobacillus), and gramnegative Bacilli (Prevotella). 
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Conclusions: The greatest antibacterial effect of Monocryl Plus suture was observed after 72 hours. According to 
most authors, there is no doubt that this antibacterial suture can provide little safety in the control of SSI.
Key words: Antibacterial suture, monocryl® plus, vicryl® plus, third molar surgery, postoperative infection, surgical 
site infection (SSI).
Introduction
The surgical extraction of impacted third molars (I3M) 
still remains one of the most commonly performed sur-
gical procedures in Oral Surgery. Surgical site infection 
(SSI) is among the postoperative local complications 
that may arise in this surgical procedure. Postopera-
tive infection rate after I3M extraction is around 5% (1). 
The incidence of SSI is related to intrinsic patient fac-
tors (immune-depression, diabetes mellitus, local or 
systemic infections, etc.) and extrinsic factors (such as 
smoking, surgical antiseptic measures, wound contami-
nation in clean, contaminated or dirty surgeries, etc) 
(2). The implantation of sutures or other devices (such 
as joint prostheses, coronary stents) is also a risk factor 
for SSI (3). It has been postulated that the number of 
bacteria required for the development of SSI is about 
100,000 times lower in the presence of suture material 
(4). For over two decades attempts have been made to 
develop sutures with antiinfectious properties. Pharma-
cologically active substances have also been incorpo-
rated on the surfaces of urethral catheters (5), coronary 
stents (6) or intraocular lenses (7). Antibacterial sutures 
composed of polyglactin 910 (Vicryl® Plus Antibacte-
rial suture), polyglecaprone 25 (Monocryl® Plus Anti-
bacterial suture) and polydioxanone (PDS® Plus Anti-
bacterial suture) with coated triclosan have been also 
developed (8-10). Different experimental studies have 
shown an important reduction in the number of micro-
organisms (including grampositive and gramnegative 
species) in the region of the surface of these sutures 
(11-13). Clinical studies in different surgical speciali-
ties have demonstrated a relative decrease in SSI (14), 
and have shown better results in terms of complications 
commonly seen in the postoperative period (15). Despite 
the low incidence of SSI after the surgical extraction of 
I3M, the oral cavity is a highly contaminated area. The 
aim of this study was to compare the antibacterial ef-
fect of Monocryl® Plus suture with silk suture, analyz-
ing the microbiological differences in terms of colonies 
forming units organisms and species.
Material and Methods
A “split-mouth” prospective clinical controlled study 
was designed involving patients treated at the Oral Sur-
gery and Implantology Department of the Faculty of 
Dentistry at the University of Barcelona (UB), Spain, 
for the surgical removal of I3M. The study was ap-
proved by the Clinical Research Ethics Committee of 
the UB. Required sample size was estimated at 16 sub-
jects to detect a difference of half the colony forming 
units in the test group using G*Power software and a 
paired t-test (effect size dz= 1; α=0.05; 1-β=0.95). Sam-
ple size was augmented to 20 subjects to compensate 
for possible losses. Surgery was performed on twenty 
healthy patients (ASA I or II) of both sexes aged be-
tween 16-45 years. Patients with systemic disease (im-
mune-depression, active infection, diabetes mellitus, 
hemostatic alterations) were excluded, as were pregnant 
women, drug abussers, patients with moderate alcohol 
consumption. Written informed consent was obtained 
from each patient, as a requirement for participation 
in the study. Four third year resident surgeons carried 
out the operations, while other 2 carried out the post-
operative clinical follow-up visits. All patients under-
went the removal of their 4 third molars presenting 
similar impaction under conscious sedation provided 
intravenously by bolus dose of 1.53 mg of midazolam, 
perfusion pump of 34 mg/kg/hour of propofol and 56 
μg/kg/hour of remifentanil. The local anesthetic used 
was 4% articaine with epinephrine 1:100,000. At least 
four simple stitches of poliglecaprone 25 suture with tri-
closan 3/0 suture (Monocryl Plus Antibacterial suture, 
Ethicon, Somerville, New Jersey, USA), were placed 
on one side and other four of braided natural black silk 
3/0 suture (Suturas Aragó, Laboratorios Aragó S.A., 
Barcelona, Spain) on the other side.  Allocation of each 
type of suture was performed using a permutation table. 
The different color of the filaments precluded operator 
and patient blinding with respect to the type of material 
used on each side. All patients received instructions on 
oral hygiene consisting of tooth brushing and cleaning 
of the surgical wounds with physiological saline rinses 
three times a day. Postoperative medication consisted 
of amoxicillin 750 mg every 8 hours for 7 days; sodium 
diclofenac 50 mg every 8 hours and metamizol magne-
sium 575 mg every 6 hours during 4 days as rescue an-
algesia. The patients rated the level of discomfort  with 
suture using a visual analog scale (VAS) scored from 0 
to 100 mm during the 7 days after surgery. The clinical 
variables subjectively registered by the two operators 
were the presence of bleeding and surgical wound sup-
Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e95-102.                                                                                                                          Pilot clinical trial of an antibacterial suture in oral surgery
e97
puration upon removing the sutures 72 hours and 7 days 
after surgery.
- Sample processing
One stitch from each operated side was removed  3 and 
7 days postoperatively, in each patient. Each suture 
sample was collected in a AMIES semisolid medium 
and analised in a microbiology laboratory. One linear 
centimeter of each stitch was sectioned, inoculated  in 1 
ml of sterile physiological saline and vortexed for 5 min-
utes to release the microorganisms adhered to the suture 
material. One microliter of the suspension was seeded 
with a different culture media and under different at-
mosphere and temperature conditions. Columbia Agar 
plates with 5% sheep blood under 5% CO2 at 35°C were 
used for  aerobic bacteria during four days. Yeasts were 
isolated using Sabouraud Agar plates with gentamycin 
and chloramphenicol at 35°C during four days. Anaero-
bic bacteria in turn were isolated using Schaedler Agar 
plates at 35°C during 7 days. Following the incubation 
process, the colonies on each plate were counted  per 
colony forming units (cfu/cm/ml). Identification was 
based on the morphological characteristics, nutritional 
requirements and biochemical tests. In relation to the 
latter, the following systems were used: API 20E  for 
Enterobacteria, API 20NE for nonfermenting gram-
negative bacilli, API NH for Neisseria spp. and Hae-
mophilus spp., API Coryne for Corynebacteria, API 20 
A  for anaerobes, Api Rapid ID32 Strep for streptococci 
and Api C AUX for yeasts.
- Scanning electron microscopy (SEM)
Examination of suture materials was carried out under a 
FEI Quanta™ 200 Scanning Electron Microscope (FEI, 
Hillsboro, USA) in high vacuum mode and 20 kV, with 
a spot size of 4 to ensure improved resolution of the 
magnified images.
- Statistical analysis
Calculation of the differences in the total counts of 
the microorganisms isolated from both types of suture 
material was carried out using the nonparametric Wil-
coxon signed rank test. The nonparametric Kendall’s W 
test was used to detect differences between the differ-
ent isolated species individually. Calculation of the dif-
ferences in the VAS pain scores was based on analysis 
of variance (ANOVA) for repeated measures, while the 
presence of bleeding was assessed with the chisquare 
test. The Statistical Package for the Social Sciences ver-
sion 17.0 (SPSS v.17.0; SPSS, Chicago, USA) was used 
for the statistical analysis, accepting statistical signifi-
cance for p<0.05.
Results
The study sample consisted of 10 men and 10 women, 
aged between 18 and 35 years, with a mean age of 23.6 
years (standard deviation (SD) of 4.77). Wound bleeding 
upon suture removal was slightly more frequent with 
silk suture though the differences were not statistically 
significant (p=0.752 and p=0.113, respectively). The de-
gree of discomfort (scored by the patients on the VAS) 
was very similar on both sutures (p=0.861), though with 
silk suture was slightly greater during the entire postop-
erative period. On day 3 there was one case of surgical 
wound infection with silk suture. The mean microor-
ganisms count after 3 days was considerably lower with 
the antibacterial suture (Table 1). In contrast, by day 7 
the difference between the two sutures had decreased 
(Table 2), though the differences between the two types 
of suture were statistically significant (p<0.001 and 
p=0.033) (Fig. 1). According to these results, there was 
mean bacterial reduction of 83% and 65%, respective-
ly. In relation to the total microorganisms count, aer-
obes were considerably more prevalent than anaerobes 
(1292 cfu/cm/ml; SD of 1230 and 349 cfu/cm/ml; SD 
of 368, respectively) (p=0.001). Silk suture showed sig-
nificantly higher values for both aerobes and anaerobes. 
Among the most frequently isolated species, mention 
must be made of Streptococcus viridans group (S. mitis, 
S. oralis, S. salivarius, S. parasanguis, S. sanguinis, S. 
anginosus and S. intermedius) Coagulase-NegativeSta-
phylococcus, Peptostreptococcus spp., Veillonella spp., 
Lactobacillus spp.  and Prevotella spp. In only one case 
was the presence of Candida spp. detected, with lower 
counts in the case of the antibacterial suture. In gen-
eral, Monocryl® Plus yielded a lower count for almost 
all the isolated species. However, the differences were 
only statistically significant after 3 days (125 cfu/cm/
ml; SD of 179 for silk suture and 28 cfu/cm/ml; SD of 
42 for Monocryl® plus suture) (p=0.013). After 7 days 
the differences had decreased (80 cfu/cm/ml; SD of 169 
and 45 cfu/cm/ml; SD of 116, respectively), though not 
significantly (p=0.197). Among the pathogenic organ-
isms isolated, mention should be made of gramnegative 
bacilli (Citrobacter freundii complex, Prevotella spp., 
Prevotella disiens and Fusobacterium spp.), anaerobic 
grampositive cocci (Peptostreptococcus spp.) and other 
unidentified strict anaerobes. The difference between 
these organisms and the commensal flora was signifi-
cantly favorable to the nonpathogenic species in both 
black silk (p=0.012) and in Monocryl® Plus suture 
(p=0.003). The most important reduction in microor-
ganisms in the antibacterial suture corresponded to the 
commensal bacteria (p=0.001). However, the presence 
of pathogenic microorganisms was also less evident 
in this suture after 72 hours and 7 days - though not 
statistically significant (Fig. 2). The scanning electron 
microscopic study showed the differences in bacterial 
colonization between the two types of suture material. 
Figures 3,4 shows the largest presence of microorgan-
isms and cellular detritus to be contained in a biofilm 
of extracellular polysaccharides at the silk suture knot 
respect to study suture.
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Discussion
Surgical site infection (SSI) is the third most common 
cause of nosocomial infections, and the most among 
surgical patients (16). Two-thirds of all cases of SSI ap-
pear in the zone of the incision. This probability is even 
greater in the presence of suture material (17). It has 
been estimated that with conventional sutures (such as 
the natural black silk), barely 100 cfu would be needed 
to induce SSI (4). Many methods have been studied to 
decrease the incidence of surgical site infection, al-
though some are uncontrollable others can be control-
led. One of these methods is the use of sutures coated 
with triclosan. In 2002, the United States Food and 
Drug Administration (FDA) authorized the use of poly-
glactin 910 coated with triclosan (Vicryl® Plus, Anti-
bacterial suture). Most studies conducted with sutures 
of this kind report a decrease in the amount of microor-
ganisms sticked to their surface. However, Venema et 
al. (18), in an in vitro study with Vicryl® Plus suture, 
recorded no bacterial inhibition zone around the suture 
with either Streptococcus sanguis PK1889 or microor-
ganisms from a human saliva sample. In contrast, ani-
mal studies have obtained favorable results. Storch et al. 
(13) reported a reduction of 96.7% with Vicryl® Plus 
suture after 48 hours in strains of S.aureus. Ming et al. 
(8), in a similar study but using Monocryl® Plus suture, 
recorded a bacterial reduction in the order of 3.4 log and 
2 log in strains of S.aureus and E. coli, respectively. 
Gómez Alonso et al. (11) in turn obtained a reduction of 
about 87% with Vicryl® Plus suture previously infected 
with S. epidermidis and E. coli. Lastly, Marco et al. (19), 
in a study using rats, reported a 66% reduction in cul-
tures positive for S.epidermidis. This is the first human 
study to date of the antibacterial action of Monocryl® 
Plus monofilament suture based on a quantitative and 
qualitative analysis of the microorganisms. This suture 
Bacteria (day 3) Silk  (DE) Monocryl Plus (DE) Reduction % p value 
Streptococcus viridans 212    (338) 42   (70) 80% 0,004 
Neisseria spp. 177    (244) 27   (35) 84% 0,001 
CN Staphylococcus 76     (226) 10   (20) 86% 0,286 
Veillonella spp  98     (247) 4    (10) 95% 0,043 
Lactobacillus spp. 73     (228) 4    (18) 94% 0,043 
Prevotella spp. 34     (113) 12   (28) 64% 0,917 
Peptostreptococcus spp. 37     (108) 6    (23) 83% 0,109 
Prevotella disiens 22     (65) 6    (18) 72% 0,273 
Citrobacter freundii complex 17     (56) 1      (2) 88% 0,180 
Actinomyces odontolyticus 12     (32) 0 100% 0,109 
Unidentified strict anaerobe 11     (29) 2      (7) 81% 0,109 
Bacillus spp. 10     (44) 8     (33) 20% 0,458 
Actinomyces spp. 8      (22) 0 100% 0,109 
Corynebacterium spp. 8      (29) 0 100% 0,109 
Gemella morbillorum 6      (23) 3    (12) 50% 0,180 
Fusobacterium spp. 4       (8) 0 100% 0,068 
Micrococcus luteus 5     (14) 0 100% 0,080 
Enterococcus spp. 1      (1) 0 100% 0,180 
 
Table 1. Mean counts of the isolated bacterial species with both suture materials 3 days after surgery. CN Staphy-
lococcus = Coagulase-negative Staphylococcus.
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provide the support necessary to maintain wound-edge 
approximation during the critical healing period (5-7 
days after surgery) due to the high initial breaking 
strength, pass smoothly through fascia to minimize tis-
sue trauma as consequence of its monofilament design 
and polymer properties that minimize drag force and 
elicit only a slight tissue reaction during absorption. 
Furthermore, protect against colonization of the suture 
by organisms commonly associated with SSIs. In our 
study colonization rate was 83% and 65% lower than 
with silk suture after 3 days (the mean bacterial count 
being up to 5fold lower than with silk suture) and 7 days 
(2fold lower) respectively. However, differences in scan-
ning electron microscope images obtained with both 
sutures, were even clearer. The complex adhesion 
mechanisms of the microorganisms that inhabit the oral 
cavity, the structural characteristics of silk suture braid-
ing, and the absence of sonication during sample 
processing probably would explain this observation 
(18,20). Triclosan is an antiseptic component with bac-
teriostatic action. At low concentrations, inhibits the 
growth of many nonsporulating grampositive and gram-
negative bacterial species. The amount added to these 
sutures reaches 1.5 μg/cm, and the range of minimum 
inhibitor concentrations (MICs) against the microor-
ganisms that inhabit the oral cavity is 0.0017.8 μg/ml 
(18). In our study, the presence of triclosan in Monocr-
yl® Plus was associated to a significant reduction of 
most microorganisms isolated during the first 2-3 days, 
though by day 7 after surgery this reduction was less 
notorious. In an in vitro study conducted by Ming et al. 
(21), the diffusion pattern was maintained for up to 21 
days. The opposite effect was recorded with silk suture, 
however - a larger number of bacterial colonies being 
observed after 3 days (778 cfu/cm/ml) than after 7 days 
(468 cfu/cm/ml) of suture placement. This phenomenon 
TABLES
Bacteria (Day 7) Silk  (DE) Monocryl Plus (DE) Reduction % p value 
Streptococcus viridans 176 (254) 138 (272) 21% 0,094 
Neisseria spp. 75  (102) 44   (79) 41% 0,231 
Staphylococcus coag. neg. 30   (59) 11   (30) 63% 0,192 
Veillonella spp  42 (121) 4    (15) 90% 0,075 
Lactobacillus spp. 23  (73) 3    (13) 86% 0,144 
Prevotella spp. 36 (112) 35  (113) 3% 0,362 
Peptostreptococcus spp. 7    (23) 2     (9) 71% 0,285 
Prevotella disiens 14  (36) 6    (14) 57% 0,144 
Citrobacter freundii complex 14  (47) 1     (2) 93% 0,180 
Actinomyces odontolyticus 9   (23) 3    (9) 66% 0,109 
Anaerobio estricto sin identificar 6   (16) 1    (4) 83% 0,144 
Bacillus spp. 6  (20) 13  (46)  0,362 
Actinomyces spp. 6  (16) 2   (10) 66% 0,285 
Corynebacterium spp. 6  (21) 1   (3) 83% 0,285 
Gemella morbillorum 4  (18) 3  (10) 25% 0,655 
Fusobacterium spp. 2   (9) 0 100% 0,317 
Micrococcus luteus 1  (5) 0 100% 0,655 
Enterococcus spp. 0 0   
Table 2.
Table 2. Mean counts of the isolated bacterial species with both suture materials 7 days after surgery. CN Staphylo-
coccus = Coagulase-negative Staphylococcus.
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appears to be related to the inability to maintain ade-
quate oral hygiene, as a result of the limitation in mouth 
opening, pain and swelling in the surgical zone still 
present on the third postoperative day. The bacterial 
flora responsible for odontogenic infections is diverse. 
In the present study, the number of bacterial species and 
colonies was greater in the case of aerobic microorgan-
isms (n = 12) than for anaerobes (n = 5), presumably as 
a result of selection of the culture media. On the other 
hand, this circumstance may possibly explain the rela-
tively low incidence of infectious complications record-
ed. Studies on oral and cervicofacial infections of odon-
togenic origin have also detected a predominantly aero-
bic flora (22,23). In the present study, the use of Monoc-
ryl® Plus suture yielded the lowest counts of both aero-
Fig. 1. Mean bacterial counts with both sutures, after 3 and 7 days. The ordinates axis expo-
nentially show the counts in cfu/cm/ml.
Fig. 2. Mean pathogen counts for both sutures, after 3 and 7 
days. The ordinates axis exponentially shows the mean counts 
in cfu/cm/ml.
Fig. 3. The natural silk suture knot material seen under the scanning 
electron microscope, 150x. 
Fig. 4. The Monocryl plus suture knot material seen under the scan-
ning electron microscope, 100x.
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bic (p=0.001) and anaerobic organisms (p=0.017). 
Streptococci belonging to the viridans group were most 
prevalent species with both sutures, followed by Neis-
seria spp. and coagulasenegative Staphylococcus. The 
unexpected presence of CoagulaseNegative Staphylo-
coccus (8.3% with silk sutures and 5.3% in the case of 
Monocryl® plus) may have been due to skin contamina-
tion of the suture filaments. The most important differ-
ence after 72 hours corresponded to the Streptococcus 
viridans group (p=0.001). The non pathogenic microor-
ganism counts were greater than the pathogens for both 
sutures, though the antibacterial suture had the lowest 
pathogen counts. With Monocryl® Plus there was a 
mean reduction of 90% for Citrobacter freundii, 78% 
for Peptostreptococcus, 33% for Prevotella spp., 64% 
for Prevotella disiens, 82% for the unidentified anaer-
obes, and 100% for Fusobacterium spp. The main ob-
jective of antibacterial sutures has been to reduce the 
SSI rate by inhibiting bacterial growth onto the surface 
of the suture material. To date, the results of the studies 
made with this suture material in humans have not been 
as good as expected. Studies in different medical and 
surgical areas (neurosurgery (14), chest surgery (24), 
general surgery (25), general pediatric surgery (15), 
plastic and reconstructive surgery (26,27) and oral sur-
gery have evaluated antibacterial sutures. We recorded 
a total of 8 studies, of which three (14,24) reported a 
reduction in the number of cases of SSI. Other authors 
however, have reported no advantage with the use of 
these antibacterial sutures (25,27). Ford et al. (15) and 
Deliaert et al. (26) recorded no SSI with the sutures 
studied in their series, and in the present study there 
was a single case of wound infection with natural silk. 
In the studies published by Mingmalairak et al. (25) and 
Chen et al. (27), surgery was carried out in highly con-
taminated areas. In contrast, the operations carried out 
in our series were regarded as clean or clean-contami-
nated surgery. Probably, in our study antibiotic prescrip-
tion in the postoperative period may have masked the 
effect associated to antibacterial suture use. Inflamma-
tory response measured by the presence of wound 
bleeding was similar with both types of suture. Surgical 
site inflammation after the extraction of I3M is difficult 
to avoid in the first 2-3 days  In contrast, after 7 days, 
wound healing is more advanced. Differences in bleed-
ing in our study were not significant, though either the 
effects of the remaining traces of triclosan or the lesser 
bacterial aggregation associated with the use of Monoc-
ryl® plus caused the inflammatory reaction to be less 
pronounced with the antibacterial suture material after 
7 days. Some experimental studies have reported a re-
duction in inflammatory response and lesser bacterial 
colonization with standard Monocryl® suture (28,29). 
No statistically significant differences were recorded in 
the level of pain experienced by the patients with the 
two suture materials. It should be noted that with the 
Monocryl® Plus suture the patients reported greater 
discomfort due to the irritation caused by the stiffness 
of the suture extremities. In contrast, Ford et al. (15) 
found polyglactin 910 with triclosan to result in less 
pain, though the areas in which this suture material was 
used were less sensitive than the oral cavity. These re-
sults may have been conditioned by the absence of 
blinding to the suture material employed, since the fila-
ments were of different colors.
Conclusions
The most significant antibacterial effect of Monocryl® 
Plus suture occurred in the first 3 days. Nevertheless, 7 
days after surgery there was some bacterial reduction vs 
silk suture. Commensal species (Streptococcus viridans 
group) were more frequently isolated than pathogenic 
organisms (Prevotella spp., Fusobacterium spp.). The 
postoperative infection rate was close to zero per cent 
with both sutures. For this reason it would be advisable 
to carry out a clinical study with a larger sample of pa-
tients in order to determine whether antibacterial sutures 
effectively contribute to lessen surgical site infections 
in patients subjected to lower third molar extractions. 
In extraction of impacted third molars, Monocryl® Plus 
suture does not seem to improve substantially of the rate 
of SSI.
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